Live Breaking News & Updates on Erin Springer Yount|Page 3
Stay updated with breaking news from Erin springer yount. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OrthoPediatrics (NASDAQ:KIDS – Get Rating) had its price objective boosted by Truist Financial from $53.00 to $57.00 in a research note issued to investors on Monday, The Fly reports. Truist Financial currently has a buy rating on the stock. A number of other research analysts also recently issued reports on KIDS. Needham & Company LLC […] ....
OrthoPediatrics Corp. (NASDAQ:KIDS – Get Rating) rose 3.7% on Thursday . The company traded as high as $49.73 and last traded at $49.73. Approximately 26,341 shares were traded during trading, a decline of 78% from the average daily volume of 119,650 shares. The stock had previously closed at $47.97. Analyst Ratings Changes KIDS has been […] ....
Monarch Partners Asset Management LLC lessened its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Get Rating) by 49.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 46,172 shares of the company’s stock after selling 44,752 shares during the quarter. Monarch Partners Asset […] ....
OrthoPediatrics (NASDAQ:KIDS – Get Rating) had its price objective increased by investment analysts at Truist Financial from $53.00 to $57.00 in a report issued on Monday, The Fly reports. Truist Financial’s price objective indicates a potential upside of 17.67% from the company’s previous close. Several other equities research analysts also recently issued reports on KIDS. […] ....
ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and OrthoPediatrics (NASDAQ:KIDS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings. Analyst Recommendations This is a breakdown of current recommendations and […] ....